India's Glenmark Life Sciences says Q4 profit soars 48 per cent on API boost https://ift.tt/H0CprQU

The Mumbai-based drug maker's profit rose to 1.46 billion rupees ($17.86 million) in the three months ended March 31, from 989 million rupees in the year-ago quarter, the company said in a regulatory filing. The company, spun off from Glenmark Pharmaceuticals Ltd in 2019 to focus on the API business, said total revenue from operations jumped nearly 21 per cent to 6.21 billion rupees in the quarter.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/XAfJqxP